Generation of high-avidity, WT1-reactive CD8+ cytotoxic T cell clones with anti-leukemic activity by streptamer technology

Leuk Lymphoma. 2017 May;58(5):1246-1249. doi: 10.1080/10428194.2016.1233538. Epub 2016 Nov 16.

Antje Tunger¹, Rebekka Wehner^{1

2}, Malte von Bonin^{2

3

4

5}, Denise Kühn⁶, Falk Heidenreich³, Sarah Matko⁷, Magdalena Nauerth⁸, Elke Rücker-Braun³, Sevina Dietz⁶, Cornelia S Link^{3

6}, Anne Eugster⁶, Marcus Odendahl⁷, Dirk H Busch⁸, Torsten Tonn^{4

5

6

7}, Ezio Bonifacio⁶, Lothar Germeroth⁹, Johannes Schetelig³, Michael P Bachmann^{2

4

5

6

10}, Martin Bornhäuser^{2

3

4

5

6}, Marc Schmitz^{1

2

4

5

6}

¹ a Institute of Immunology, Medical Faculty , TU Dresden , Dresden , Germany.
² b National Center for Tumor Diseases , University Hospital Carl Gustav Carus, TU Dresden , Germany.
³ c Department of Medicine I , University Hospital of Dresden , Dresden , Germany.
⁴ d German Cancer Consortium (DKTK) , Dresden , Germany.
⁵ e German Cancer Research Center (DKFZ) , Heidelberg , Germany.
⁶ f Center for Regenerative Therapies Dresden (CRTD), Medical Faculty, TU Dresden , Dresden , Germany.
⁷ g Institute of Transfusion Medicine, German Red Cross Blood Donation Service North-East , Dresden , Germany.
⁸ h Institute for Medical Microbiology, Immunology and Hygiene, TU Munich , Munich , Germany.
⁹ i Juno Therapeutics GmbH , Göttingen , Germany.
¹⁰ j Department of Radioimmunology , Institute of Radiopharmaceutical Cancer Research, Helmholtz Center Dresden-Rossendorf , Dresden , Germany.

No abstract available

Publication types